Clinical Trial Update: Effects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid Haemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the effects of prostacyclin infusion on cerebral vessels and brain metabolism in patients with subarachnoid hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• Prostacyclin (epoprostenol)

Snippet

Sponsor: Rune Rasmussen | Conditions: Subarachnoid Hemorrhage | Phase 2 | Status: COMPLETED